Evidence map›Paper›PMID 32188043›Full record

ArticleMedicina (Kaunas, Lithuania)2020

Himal Luitel, Tatyana Novoyatleva, Akylbek Sydykov, Aleksandar Petrovic, Argen Mamazhakypov, Bhuminand Devkota, Malgorzata Wygrecka, Hossein Ardeschir Ghofrani, Sergey Avdeev, Ralph Theo Schermuly and 1 more

Abstract read
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Potential of the TRPM7 channel as a novel therapeutic target for pulmonary arterial hypertension.Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Himal LuitelUniversities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), 35392 Giessen, Germany.
Tatyana NovoyatlevaUniversities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), 35392 Giessen, Germany.
Akylbek SydykovUniversities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), 35392 Giessen, Germany.ORCID 0000-0002-8122-7033
Aleksandar PetrovicUniversities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), 35392 Giessen, Germany.
Argen MamazhakypovUniversities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), 35392 Giessen, Germany.ORCID 0000-0002-2140-4819
Bhuminand DevkotaVeterinary Science (Theriogenology), Agriculture and Forestry University (AFU), Center for Biotechnology, 44209 Rampur, Chitwan, Nepal.
Malgorzata WygreckaUniversities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), 35392 Giessen, Germany.ORCID 0000-0002-3656-2932
Hossein Ardeschir GhofraniUniversities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), 35392 Giessen, Germany.
Sergey AvdeevDepartment of Pulmonology, Sechenov First Moscow State Medical University (Sechenov University), 119992 Moscow, Russia.ORCID 0000-0002-5999-2150
Ralph Theo SchermulyUniversities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), 35392 Giessen, Germany.
Djuro KosanovicUniversities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), 35392 Giessen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsAntifungal AgentsBiocompatible MaterialsCase-Control StudiesCell ProliferationCordycepsDeoxyadenosinesHumansHypertension, PulmonaryLungMiceMice, Inbred C57BLMuscle, Smooth, VascularOxidative StressPlacebosVasodilator AgentsAntifungal AgentsBiocompatible MaterialscordycepinDeoxyadenosinesPlacebosVasodilator Agentsbiomaterialcordycepinpulmonary hypertensionpulmonary vascular smooth muscle cellspulmonary vasodilatationYarsagumba

Identifiers

PMID32188043
PMCPMC7142425

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.